Lupin Picks Up Canadian Approval For Enbrel Biosimilar

Rymti Version Of Etanercept Is Third Rival To Be Approved By Health Canada

 
• By Dave Wallace
  
Canada flag five vials syringes
Health Canada has approved Lupin’s Rymti etanercept biosimilar • Source: Shutterstock

More from Biosimilars

More from Products